Economy

Ravi Teja's 'Raja The Great' title track to be out soon!

Ravi Teja's 'Raja The Great' title track to be out soon!”

While his fans have been waiting eagerly for the release of these two films within a short interval, sources in the industry have now come up with the info that Ravi Teja has shifted his focus entirely on Raja the Great. Makers have released the first song of Raja The Great today (September 18) at 6 pm. The recently released teaser of the film managed to get good response and has upped the expectations on the film.

Film's producer Dil Raju share the Raja The Great Title Song link on social media and wrote, '#RajaTheGreat Intro song is live now. "Enjoy the super mass beats". This Anil Ravipudi directorial features Ravi Teja as a blind man and Mehreen played the female lead. Anil Ravipudi is already assuring the best entertainment for this movie right from starting to end. Raashi Khanna is also a part of the movie but a cameo kind of role. Ravi Teja pinned all his hopes on the film which is said to be made on a decent budget. The film is planning to release on 12 October 2017. Sai Karthik has wielded the music baton for this movie with Mohana Krishna roped in for the cinematography and Tammi Raju is editing Raja the Great.



Like this

loading...
loading...

Latest


19 September 2017
Has $1.15 Million Holdings in Henry Schein, Inc. (HSIC)
The Connecticut-based Cubist Systematic Strategies Ltd Com has invested 0.06% in PAREXEL International Corporation (NASDAQ:PRXL). In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the firm's stock in a transaction on Wednesday, September 6th.

19 September 2017
Renault, Nissan and Mitsubishi team up on self-driving and electric cars
The automakers plan to release their first fully autonomous vehicle , requiring no human driver at all, in about five years. By the end of our strategic plan Alliance 2022, we aim to double our annual synergies to €10 billion.

19 September 2017
Man United send scouts to watch Radja Nainggolan
Carrick was handed the Manchester United captains armband following the departure of Wayne Rooney to Everton this summe. The midfielder joined the Red Devils in 2006 from Tottenham and has so far made a total of 459 appearances for United.

19 September 2017
Rob Kardashian shared an adorable photo of his "twin" daughter Dream
Chyna is pleased that Rob has agreed to peacefully co-parent Dream with her, as she has been requesting all along. Remember, last July, Rob Kardashian published on his account Instagram pictures of Blac Chyna completely naked.

18 September 2017
Australia dealing with 'horrific' flu season
Auckland City Hospital said it had had the "busiest July ever" this year, with 136 influenza hospital admissions - up from just 41 in July last year.

18 September 2017
Child Passenger Safety Week: Keep Young Ones Safe
Once the rear-facing size limit is reached, the child is ready to travel in a forward-facing auto seat with a harness and tether. Children 2 years of age to 5 years of age or weighing less than 40 lbs. must use a child restraint that has a 5-point harness.

18 September 2017
Patriots LB Dont'a Hightower receives second opinion on knee injury
Hightower (knee), Slater (hamstring), Amendola (knee, concussion), Ebner (shoulder) and Valentine (knee) had already been ruled out prior to Sunday.

18 September 2017
The Goodyear Tire & Rubber Co (GT) Receives $34.82 Consensus PT from Brokerages
The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.74 by $0.11. Financial Architects Inc raised its holdings in shares of The Goodyear Tire & Rubber by 2.2% during the second quarter.

18 September 2017
Fosun to acquire Gland Pharma, with smaller stake
Raju, will remain on the Gland board and the current management team will continue to run the company. Fosun Pharma shares yesterday jumped as much as 4.3 percent in Shanghai.

18 September 2017
Investment Research Analysts Opinion: Forterra, Inc. (FRTA), Arrowhead Pharmaceuticals, Inc. (ARWR)
ARWR is now overvalued by 135.33% relative to the average 1-year price target of $1.50 taken from a group of Wall Street Analysts. Analysts have placed a $1.5 price target on Arrowhead Pharmaceuticals, Inc., suggesting a -56.27% decline from recent close.